Expand HCWB Menu
HCWB MENU

HCWB Stock Summary and Trading Ideas (HCW Biologics | NASDAQ:HCWB)

HCW Biologics (HCWB) Frequently Asked Questions

What does HCW Biologics do?

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

What symbol and exchange does HCW Biologics shares trade?

HCW Biologics trades on the NASDAQ stock market under the symbol HCWB.

What is HCW Biologics stock price doing today?

As of January 14, 2026, HCWB stock price declined to $1.15 with 19,756 million shares trading.

What is HCW Biologics's Beta?

HCWB has a beta of 2.37, meaning it tends to be more sensitive to market movements. HCWB has a correlation of 0.10 to the broad based SPY ETF.

How much is HCW Biologics worth?

HCWB has a market cap of $3.77 million. This is considered a Sub-Micro Cap stock.

How much money does HCW Biologics make?

Last quarter HCW Biologics reported $16 million in Revenue and -$2.02 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$3.60.

What is the highest and lowest price HCW Biologics traded in the last 3 year period?

In the last 3 years, HCWB traded as high as $100.80 and as low as $.95.

What are the top ETFs holding HCW Biologics?

The top ETF exchange traded funds that HCWB belongs to (by Net Assets): VXF.

Is HCW Biologics (HCWB) a good investment?

HCWB has underperformed the market in the last year with a return of -92.1%, while the SPY ETF gained +20.0%. In the last 3 month period, HCWB fell short of the market, returning -72.7%, while SPY returned +4.4%. However, in the most recent 2 weeks HCWB has outperformed the stock market by returning +1.4%, while SPY returned +0.5%.

What are the support and resistance levels for HCW Biologics (HCWB)?

HCWB support price is $1.10 and resistance is $1.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCWB shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes